Publication | Closed Access

Novel dual-targeting anti-proliferative dihydrotriazine-chalcone derivatives display suppression of cancer cell invasion and inflammation by inhibiting the NF-κB signaling pathway

Medicinal ChemistryMedicineImmunologyTumor ImmunityCancer Cell BiologyCancer Cell InvasionCancer BiologyAnti-cancer AgentCancer TreatmentPharmacologyNf-κb Signaling PathwayCancer ResearchTumor BiologyDrug Discovery